Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Cell Culture Media, Sera and Reagents Market $6.1 Billion by 2027

The global market for cell culture media, sera and reagents expected to become $6.1 billion by 2027, expanding at a CAGR of 11.4% throughout the forecast period, driven by increasing demand for manufacturing biopharmaceuticals and biologics worldwide.

  • Other factors significantly boosting the cell culture media, sera and reagents market growth include rise in contract research and manufacturing operations, and larger dependence on the use of serum-free, custom media by the biopharmaceutical industry.
    • However, stringent regulatory controls for manufacturing (cGMP – current good manufacturing practices) and ethical concerns regarding the use of animal-based products are the growth restraining factors during forecast period.
Global Cell Culture Media, Sera and Reagents Market

There are different media requirement for various cell types. Serum based media are widely used to grow a broad range of animal cell lines. Serum is a complex mix of albumin, growth factors and growth inhibitors which is also a source of amino acids, proteins, vitamins (A, D, E, and K), carbohydrates, lipids, hormones, growth factors, minerals, and trace elements.

  • Cell culture components or reagents provide an ideal growth environment as per the cell types. The cell culture media, sea and reagent products have been extensively used in cell culture and antibody production to vaccine development and drug discovery.
Cell Culture Media, Sera, and Reagents Market

The global cell culture media, sera and reagents market report estimates the market size ($million 2017 to 2027), market share analysis, growth trends and forecast (CAGR% 2021 to 2027).

The global market for cell culture media, sera and reagent products segmented by media type (chemically defined media, classical media, lysogeny broth, protein-free media, serum-free media, specialty media), serum type (fetal bovine, newborn calf and adult bovine sera, others), reagent type [albumin (bovine serum albumin, human serum albumin, recombinant serum albumin), amino acids, attachment factors, growth factors and cytokines (HumanKine growth factors and cytokine, insulin-like growth factors, tumor necrosis factor, others), hormones (insulin, recombinant insulin, erythropoietin, others), other products (porcine trypsin, recombinant trypsin, thrombin, miscellaneous reagents)], and geography.

  • Among the cell culture media sub-segments, the classical media segment accounted for the largest share of the total market followed by the chemically-defined media segment, and closely followed by the lysogeny broth (LB) media segment. 
    • Availability of classic media in various quantities and wide formulation variations are driving the market. However, specialty media and LB media are projected to show double-digit growth rate over the forecast period.
  • In the recent years, the demand for media has been shifting towards serum-sparing, and serum-free animal derived media,  from the conventional serum-based and chemically-defined media.
    • There has been a significant increase in demand for specialty media that supports the growth of specific cell types.
  • The fetal bovine serum (FBS) is the most common sera type used in cell culture medium. FBS held the largest share of the cell culture sera segment, as It is composed of several growth factors and low level of antibodies with high applicability in many cell culture applications.
    • However, ethical concerns have led researchers and manufacturers to look for alternatives such as newborn calf serum, calf serum, donor calf serum, bovine serum, donor bovine serum, horse serum, donor horse serum, porcine serum, goat and sheep serum, and human serum.
      • The other serums segment are expected show double-digit growth throughout the forecast period.

The global market for cell culture media, sera and reagent products report is divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • In terms of geography, the emerging economies of the Asia Pacific and Latin America regions are anticipated to contribute towards the growth of cell culture products market over the forecast period.
  • Technological advances in better specificity and sensitivity of cell culture products as well as low cost and robustness of cell culture optimization protocols are some factors would increase the its demand in research, development and manufacturing of biologics.

The global market research report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global cell culture media, sera and reagent products market and profiled in this report include Becton, Dickinson and Company, Corning Life Sciences B.V., EMD Millipore, GE Healthcare, Lonza Group Ltd., PromoCell GmbH, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific, Inc., VWR International, LLC, and Wheaton Industries, Inc.

  • Media
    • Chemically Defined Media
    • Classical media
    • Lysogeny broth (LB)
    • Protein-free media
    • Serum-free media
    • Specialty media
  • Sera
    • Fetal Bovine
    • Newborn Calf and Adult Bovine Sera
    • Others
  • Reagent
    • Albumin
      • Bovine Serum Albumin (BSA)
      • Human Serum Albumin (HSA)
      • Recombinant Serum Albumin (RSA)
    • Amino Acids
    • Attachment Factors
    • Growth Factors & Cytokines
      • HumanKine Growth Factors and Cytokine
      • Insulin-like Growth Factors (IGF)
      • Tumor Necrosis Factor (TNF)
      • Others
    • Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others)
    • Others
      • Porcine Trypsin
      • Recombinant Trypsin
      • Thrombin
      • Miscellaneous Reagents
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Becton, Dickinson and Company
    • Corning Life Sciences B.V.
    • EMD Millipore
    • GE Healthcare
    • Lonza Group Ltd.
    • PromoCell GmbH
    • Sigma-Aldrich Co. LLC
    • Thermo Fisher Scientific, Inc.
    • VWR International, LLC
    • Wheaton Industries, Inc.

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]